+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 1mil | ||||||
---|---|---|---|---|---|---|---|
タイトル | TRANSFORMING PROTEIN | ||||||
![]() | SHC ADAPTOR PROTEIN | ||||||
![]() | TRANSFORMING PROTEIN / SH2 DOMAIN / PHOSPHORYLATION / COLLAGEN / GROWTH REGULATION / ALTERNATIVE INITIATION | ||||||
機能・相同性 | ![]() regulation of superoxide metabolic process / positive regulation of cell proliferation in bone marrow / XBP1(S) activates chaperone genes / neurotrophin TRKA receptor binding / transmembrane receptor protein tyrosine kinase adaptor activity / Interleukin-15 signaling / Interleukin-2 signaling / Shc-EGFR complex / epidermal growth factor binding / epidermal growth factor receptor binding ...regulation of superoxide metabolic process / positive regulation of cell proliferation in bone marrow / XBP1(S) activates chaperone genes / neurotrophin TRKA receptor binding / transmembrane receptor protein tyrosine kinase adaptor activity / Interleukin-15 signaling / Interleukin-2 signaling / Shc-EGFR complex / epidermal growth factor binding / epidermal growth factor receptor binding / Signaling by ALK / RET signaling / Activated NTRK3 signals through RAS / Activated NTRK2 signals through RAS / Interleukin-3, Interleukin-5 and GM-CSF signaling / SHC1 events in ERBB4 signaling / Signalling to RAS / SHC-related events triggered by IGF1R / Role of LAT2/NTAL/LAB on calcium mobilization / Signal attenuation / Interleukin receptor SHC signaling / SHC-mediated cascade:FGFR3 / MET activates RAS signaling / SHC-mediated cascade:FGFR2 / SHC-mediated cascade:FGFR4 / SHC-mediated cascade:FGFR1 / Erythropoietin activates RAS / Signaling by CSF3 (G-CSF) / Tie2 Signaling / SHC1 events in EGFR signaling / ephrin receptor binding / phosphotyrosine residue binding / SHC1 events in ERBB2 signaling / Integrin signaling / Constitutive Signaling by Overexpressed ERBB2 / FCERI mediated Ca+2 mobilization / Insulin receptor signalling cascade / negative regulation of angiogenesis / insulin-like growth factor receptor signaling pathway / FCERI mediated MAPK activation / Signaling by ERBB2 TMD/JMD mutants / insulin-like growth factor receptor binding / Constitutive Signaling by EGFRvIII / insulin receptor binding / Signaling by ERBB2 ECD mutants / Signaling by ERBB2 KD Mutants / epidermal growth factor receptor signaling pathway / phospholipid binding / receptor tyrosine kinase binding / cellular response to growth factor stimulus / cell-cell adhesion / GPER1 signaling / Signaling by CSF1 (M-CSF) in myeloid cells / Signaling by ALK fusions and activated point mutants / insulin receptor signaling pathway / Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants / DAP12 signaling / heart development / actin cytoskeleton organization / RAF/MAP kinase cascade / angiogenesis / positive regulation of MAPK cascade / Extra-nuclear estrogen signaling / positive regulation of ERK1 and ERK2 cascade / intracellular signal transduction / mitochondrial matrix / defense response to bacterium / focal adhesion / negative regulation of DNA-templated transcription / positive regulation of cell population proliferation / negative regulation of apoptotic process / positive regulation of DNA-templated transcription / plasma membrane / cytosol 類似検索 - 分子機能 | ||||||
生物種 | ![]() | ||||||
手法 | ![]() | ||||||
![]() | Mikol, V. | ||||||
![]() | ![]() タイトル: Crystal structure of the SH2 domain from the adaptor protein SHC: a model for peptide binding based on X-ray and NMR data. 著者: Mikol, V. / Baumann, G. / Zurini, M.G. / Hommel, U. #1: ![]() タイトル: Crystallization of the Complex between Cyclophilin a and Cyclosporin Derivatives: The Use of Cross-Seeding 著者: Mikol, V. / Duc, D. #2: ![]() タイトル: X-Ray Structure of a Monomeric Cyclophilin A-Cyclosporin a Crystal Complex at 2.1 A Resolution 著者: Mikol, V. / Kallen, J. / Pflugl, G. / Walkinshaw, M.D. #3: ![]() タイトル: A Novel Transforming Protein (Shc) with an Sh2 Domain is Implicated in Mitogenic Signal Transduction 著者: Pelicci, G. / Lanfrancone, L. / Grignani, F. / Mcglade, J. / Cavallo, F. / Forni, G. / Nicoletti, I. / Grignani, F. / Pawson, T. / Pelicci, P.G. | ||||||
履歴 |
|
-
構造の表示
構造ビューア | 分子: ![]() ![]() |
---|
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 34 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 22.6 KB | 表示 | ![]() |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
文書・要旨 | ![]() | 362.3 KB | 表示 | ![]() |
---|---|---|---|---|
文書・詳細版 | ![]() | 365.3 KB | 表示 | |
XML形式データ | ![]() | 3.9 KB | 表示 | |
CIF形式データ | ![]() | 5.8 KB | 表示 | |
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
-関連構造データ
-
リンク
-
集合体
登録構造単位 | ![]()
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
単位格子 |
|
-
要素
#1: タンパク質 | 分子量: 11713.277 Da / 分子数: 1 / 断片: PHOSPHOTYROSINE RECOGNITION DOMAIN SH2 / 由来タイプ: 組換発現 / 由来: (組換発現) ![]() ![]() ![]() | ||
---|---|---|---|
#2: 水 | ChemComp-HOH / | ||
構成要素の詳細 | RESIDUE ARG 16 OF SHC ADOPTS ALTERNATE CONFORMATI配列の詳細 | RESIDUES 1 AND 2 CORRESPOND TO RESIDUES OF THE T7 GENE LEADER SEQUENCE REQUIRED FOR EXPRESSION AND ...RESIDUES 1 AND 2 CORRESPOND | |
-実験情報
-実験
実験 | 手法: ![]() |
---|
-
試料調製
結晶 | マシュー密度: 2.28 Å3/Da / 溶媒含有率: 46.05 % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
結晶 | *PLUS 溶媒含有率: 46.2 % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
結晶化 | *PLUS 温度: 22 ℃ / pH: 5 / 手法: 蒸気拡散法, ハンギングドロップ法 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶液の組成 | *PLUS
|
-データ収集
放射 | 散乱光タイプ: x-ray |
---|---|
放射波長 | 相対比: 1 |
反射 | 解像度: 2.7→10 Å / Num. obs: 3028 / % possible obs: 94 % / Observed criterion σ(I): 2 |
反射 | *PLUS Num. measured all: 7344 / Rmerge(I) obs: 0.051 |
-
解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 解像度: 2.7→8 Å / σ(F): 2 /
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 2.7→8 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化 | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | *PLUS |